LYRA THERAPEUTICS INC
LYRA
LYRA was delisted on the 16th of March, 2026.
26 hedge funds and large institutions have $20.2M invested in LYRA THERAPEUTICS INC in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 9 closing their positions.
0.02% less ownership
Funds ownership: 0.79% → 0.77% (-0.02%)
10% less capital invested
Capital invested by funds: $22.4M → $20.2M (-$2.19M)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
21% less funds holding
Funds holding: 33 → 26 (-7)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Clearline Capital
New York
|
+$242K |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$122K |
| 3 |
JP Morgan Chase
New York
|
+$30.3K |
| 4 |
PVI
Pura Vida Investments
New York
|
+$14.5K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.37K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$177K |
| 2 |
Two Sigma Advisers
New York
|
-$161K |
| 3 |
Renaissance Technologies
New York
|
-$152K |
| 4 |
Two Sigma Investments
New York
|
-$77K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$58K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Citadel Advisors
Miami,
Florida
| – | -$58K | -265 | Closed |
|
|
VF
27
Virtu Financial
New York
| – | -$57K | -263 | Closed |
|
28
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$49K | -224 | Closed |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| – | -$47K | -213 | Closed |
|
|
SCM
30
Soleus Capital Management
Greenwich,
Connecticut
| – | -$44K | -200 | Closed |
|
31
UBS Group
Zurich,
Switzerland
| – | -$17.8K | -81 | Closed |
|
32
Koshinski Asset Management
Decatur,
Illinois
| – | -$872 | -4 | Closed |
|
|
CA
33
CoreCap Advisors
Southfield,
Michigan
| – | -$1K | -3 | Closed |
|
|
PFS
34
Prospera Financial Services
Dallas,
Texas
| – | +$439 | +2 | New |
|
LYRA Hedge Fund Activity: Q1 2022 in Review
26 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q1 2022, worth a combined $20.2M — down 9.8% from $22.4M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of LYRA and 2 opened new positions — a net loss of 7 holders — while 7 trimmed existing stakes and 6 added.
The largest buyer was Clearline Capital, adding an estimated $242K. The largest seller was Millennium Management, cutting an estimated $177K.
- 26 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q1 2022, down from 33 in Q4 2021.
- Funds reported $20.2M of LYRA THERAPEUTICS INC stock for Q1 2022, down 9.8% quarter-over-quarter.
- 2 funds opened new LYRA THERAPEUTICS INC positions in Q1 2022 and 9 closed out, a net change of -7 holders.
- The largest LYRA THERAPEUTICS INC buyer in Q1 2022 was Clearline Capital, an estimated $242K added.
- The largest LYRA THERAPEUTICS INC seller in Q1 2022 was Millennium Management, an estimated $177K sold.
Based on aggregated 13F filings for Q1 2022.